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LETTER TO THE EDITOR

Breakout of Vaping-associated Lung Injuries (VALI)
2019: A Public Health Threat

of infection after workup and no evidence of an alternative
cause (cardiac, rheumatologic, or neoplastic).1-4

Sir,
A previously healthy 20 years young man presented in the Emergency Department with worsening shortness of breath for the
last two days. He denied any history of alcohol use or smoking.
He also denied any history of using additives while vaping.
There was no fever, no recent travel history or ﬂu-like illness. He
was a college student with no occupational exposure to any allergens or industrial fumes. He gave the history of using ﬂavoured
e-cigarettes for 2-3 months. Later, he developed intractable
cough and was prescribed oral azithromycin by his primary
physician, with no relief. On physical examination, he was
febrile, tachycardic and tachypneic with oxygen saturation of
66% on room air. He had bilateral crepitation on lung auscultation.
Laboratory work-up showed leukocytosis with neutrophilic shift
(total white cell counts 20 x 109/L with neutrophils 18 x 109/L).
Septic work-up showed raised C-reactive protein of 30 mg/L.
Moreover, echocardiogram was unremarkable. He got intubated due to hypoxemic respiratory failure, increased work of
breathing with respiratory rate of 50 breaths per minute. There
were multiple tiny nodules with no deﬁnite inﬁltrates or consolidation seen on chest X-ray (Figure 1). His blood gas values postintubation showed pH of 7.34, PCO2 of 50 mm Hg and PO2 of 75
mm Hg. Rest of the tests’ results were unremarkable. Piperacillin-tazobactam was administered as intravenous antibiotics
and he was shifted to the intensive care unit. Later, he got extubated, observed for two days in ward and was discharged
uneventfully. CT chest was not performed due to ﬁnancial
restraints. With the background of vaping with ﬂavoured eliquid, it was strongly suspected that his vaping exposure posed
a diagnostic challenge. Other possibilities for diﬀerential diagnosis such as viral or bacterial pulmonary infections, occupational lung diseases or cardiac conditions were excluded. Such
case made us to be knowledgeable about vaping-related lung
injury (VALI).
Battery operated electronic cigarettes or e-cigarettes are used
to inhale nicotine and additive agents. There has been no largescale study identifying such exposure till 2019, when several
journals and health departments reporting such cases as a
public health concern. Potentially toxic chemicals such as nicotine, carbonyls, benzene, toluene are shown as key ingredients
in vaping.
According to the Center of Disease Control (CDC), VALI is
deﬁned as the use of e-cigarette or vaping in the 90 days before
symptom onset, pulmonary inﬁltrate (opacities on chest X-ray
or ground glass opacities on computed tomography), absence
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Figure 1: Chest X-ray showing bilateral nodularity in lung ﬁelds.

Vaping devices in the form of easy-to-carry pens and USB ﬂash
drives have been aggressively marketed. It was ﬁrst introduced
in the US in 2006. Literature highlighted the short and long term
health eﬀects of vaping and its comparison with traditional
cigarettes. CDC reported VALI with worsening symptoms
including shortness of breath, fever, cough, vomiting, diarrhea,
headache, dizziness and chest pain. Range of symptoms and
imaging were correlated with chemical pneumonitis. Patients
required ICU care with mechanical ventilation due to severe
respiratory failure.
As of early September 2019, approximately 450 cases in the
United States were reported with mortality in ﬁve cases.5,6 The
largest case number (150-199) was reported from Texas and
Ilinois of United States with 47 deaths.2
The pathogenesis of VALI is yet to be discovered; however,
multiple compounds were identiﬁed as potential risk factors
such as diacetyl, nickel, tin, and lead; no speciﬁc liquid or device
has been identiﬁed as the causative agent. VALI has been
reported with nicotine, tetrahydrocannabinol and cannabidiol
products. Laboratory and imaging ﬁndings are non-speciﬁc.
Bronchoscopy samples showed neutrophilia and lipid laden
macrophages.
The patterns of lung injury reported with VALI include acute
eosinophilic pneumonia, lipoid pneumonia, acute lung injury
and acute respiratory distress syndrome, acute and subacute
hypersensitivity pneumonitis, organizing pneumonia, acute
eosinophilic pneumonia, diﬀuse alveolar hemorrhage, and
respiratory bronchiolitis-associated pneumonitis.3,6
Emergency physicians should inquire speciﬁcally about e-cigarette use in any patient presenting with acute lung disease.
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VALI is changing into an epidemic with under-reported
numbers. In anticipation of rise of respiratory illnesses during
inﬂuenza season, the CDC updated its guidance for VALI to help
diﬀerentiate these patients from those with seasonal illnesses,
like inﬂuenza. The guidance includes recommendations for
physicians to ask patients with respiratory or gastrointestinal
illness, if they have used vaping products or corticosteroids.
Also, a reminder was included that not all patients with VALI
need to be hospitalised; but they can be managed as outpatients if they have normal blood oxygen levels, no respiratory
distress, and reliable access to health care.4-6 Regional data is
non-existent till now. There is also a dire need to notify the
reported cases to health authorities and spread the awareness
about vaping, which may be considered as a safe option for
smoking alternatives, its marketing and testing of e-liquid
components.
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